Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
The detection of acquired copy-number abnormalities (CNAs) and copy-neutral loss of heterozygosity (CN-LOH) in neoplastic disorders by chromosomal microarray analysis (CMA) has significantly increased over the past few years with respect to both the number of laboratories utilizing this technology a...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2019
|
在線閱讀: | https://doi.org/10.1038/s41436-019-0545-7 https://www.nature.com/articles/s41436-019-0545-7.pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|